178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

Detalhes bibliográficos
Main Authors:	Li Liu, Simon Turcotte, Shari Pilon-Thomas, Doris Wiener, Brian Czerniecki, Matthew Beatty, Larissa Pikor, Urminder Singh, Christian E Laing, Jacob Gibson, Anna Kluew, Mahdi Golkaram, Sven Bilke, Nathalie Brassard, Stewart E Abbot, Timothy J Langer, Grace DeSantis, Michael J Ciancanelli, Jeff H Tsai
Formato:	Artigo
Idioma:	English
Publicado em:	BMJ Publishing Group 2023-11-01
Colecção:	Journal for ImmunoTherapy of Cancer

Registos relacionados

900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
Por: Quanyuan He, et al.
Publicado em: (2023-11-01)

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
Por: Amy Hall, et al.
Publicado em: (2023-11-01)

Tumor neoantigens and tumor immunotherapies
Por: Wang Jiani, et al.
Publicado em: (2024-04-01)

Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
Por: Meng Jia, et al.
Publicado em: (2023-10-01)

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.
Por: Mahdi Golkaram, et al.
Publicado em: (2020-11-01)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Por: Markus W. Löffler, et al.
Publicado em: (2019-04-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
Por: Kim Bich Nguyen, et al.
Publicado em: (2023-08-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Por: Zhe Jing, et al.
Publicado em: (2022-08-01)

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Por: Stefani Spranger, et al.
Publicado em: (2024-11-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
Por: Vladimir Roudko, et al.
Publicado em: (2020-01-01)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
Por: Brandon Mistretta, et al.
Publicado em: (2023-09-01)

Utilization of primary tumor samples for cancer neoantigen discovery
Por: Yong Li, et al.
Publicado em: (2025-01-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
Por: Yanwei Shen, et al.
Publicado em: (2022-08-01)

Inducible de novo expression of neoantigens in tumor cells and mice
Por: Damo, Martina, et al.
Publicado em: (2021)

Inducible de novo expression of neoantigens in tumor cells and mice
Por: Damo, Martina, et al.
Publicado em: (2022)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
Por: Truex, Nicholas, et al.
Publicado em: (2020)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Por: Berta Segura-Collar, et al.
Publicado em: (2023-05-01)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
Por: Vrunda Trivedi, et al.
Publicado em: (2024-01-01)

The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
Por: Shefali Mehra, et al.
Publicado em: (2024-01-01)

Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
Por: Xiaoyu Huang, et al.
Publicado em: (2024-03-01)

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
Por: Guadalupe Nibeyro, et al.
Publicado em: (2023-07-01)

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Por: Berta Segura-Collar, et al.
Publicado em: (2023-07-01)

The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
Por: Ahmet Murat Aydin, et al.
Publicado em: (2021-02-01)

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
Por: Shari Pilon-Thomas, et al.
Publicado em: (2023-10-01)

Analysis of Somatic Mutations in the TCGA-LIHC Whole Exome Sequence to Identify the Neoantigen for Immunotherapy in Hepatocellular Carcinoma
Por: Swetha Pulakuntla, et al.
Publicado em: (2023-12-01)

Unraveling the power of NAP-CNB’s machine learning-enhanced tumor neoantigen prediction
Por: Almudena Mendez-Perez, et al.
Publicado em: (2025-03-01)

TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
Por: Jingcheng Wu, et al.
Publicado em: (2018-08-01)

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Por: Celina Tretter, et al.
Publicado em: (2023-08-01)

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
Por: Kai Xin, et al.
Publicado em: (2024-12-01)

Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy
Por: Ting Su, et al.
Publicado em: (2023-08-01)

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Por: Jiangping Li, et al.
Publicado em: (2023-08-01)

Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
Por: Songming Peng, et al.
Publicado em: (2019-09-01)

TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
Por: Yunxia Tang, et al.
Publicado em: (2020-11-01)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
Por: Manisit Das, et al.
Publicado em: (2020-12-01)

Whole exome-seq and RNA-seq data reveal unique neoantigen profiles in Kenyan breast cancer patients
Por: Godfrey Wagutu, et al.
Publicado em: (2024-12-01)

The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
Por: Sang Hoon Kim, et al.
Publicado em: (2024-06-01)

1461 Induction of clonal expansion of tumor-reactive T cells and effective tumor suppression by neoantigens predicted from the ‘VACINUS‘ platform
Por: Sang Hoon Kim, et al.
Publicado em: (2023-11-01)

Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue.
Por: Julanee Leenanitikul, et al.
Publicado em: (2023-01-01)

Chemically modified neoantigen-based immunotherapy for targeting KRASG12C-driven tumors
Por: Abdel Mouti, M, et al.
Publicado em: (2023)

Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens
Por: Jie Jiang, et al.
Publicado em: (2025-02-01)